Anondita Medicare Ltd

Anondita Medi. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anondita Medicare Ltd

₹ 681 -2.04%
20 Mar - close price
anonditamedicare.com NSE - SME: ANONDITA
About

Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]

Key Points

Business Profile[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.

Website NSE - SM
  • Market Cap ₹ 1,231 Cr.
  • Current Price ₹ 681
  • High / Low ₹ 1,037 / 262
  • Stock P/E 53.6
  • Book Value ₹ 60.1
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE 41.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 11.3 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Sep 2025
31 54
22 35
Operating Profit 10 19
OPM % 31% 35%
0 0
Interest 1 2
Depreciation 0 0
Profit before tax 8 17
Tax % 25% 25%
6 13
EPS in Rs 4.29 7.11
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
77
51
Operating Profit 26
OPM % 33%
0
Interest 3
Depreciation 1
Profit before tax 22
Tax % 25%
16
EPS in Rs 11.88
Dividend Payout % 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 42%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Sep 2025
Equity Capital 13 18
Reserves 25 91
27 47
13 21
Total Liabilities 78 176
14 13
CWIP 6 15
Investments 3 3
55 145
Total Assets 78 176

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
-10
-23
33
Net Cash Flow -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
Debtor Days 127
Inventory Days 141
Days Payable 40
Cash Conversion Cycle 228
Working Capital Days 129
ROCE %

Insights

In beta
Jan 2026 Mar 2027 (P)
Installed Manufacturing Capacity
million pieces per annum ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Capacity Under Trial Production
million pieces per annum ・Standalone data
Existing Capacity Utilization
million pieces per annum ・Standalone data
Existing Capacity Utilization (%)
% ・Standalone data
IPO Proceeds Re-allocation to Working Capital
INR Lakhs ・Standalone data
IPO Proceeds Utilized (Total)
INR Lakhs ・Standalone data
IPO Unutilized Amount
INR Lakhs ・Standalone data
L1 GeM Tender Supply Volume (Condoms)
pieces ・Standalone data
L1 GeM Tender Supply Volume (Family Planning Items)
pieces ・Standalone data
Order Value (CMSS GeM Tender)
INR ・Standalone data
Projected Turnover for FY2025-26
INR Crores ・Standalone data
Target Capacity Expansion (Noida Facility)
million pieces per annum ・Standalone data

Shareholding Pattern

Numbers in percentages

8 Recently
Sep 2025
61.79%
4.24%
6.55%
27.42%
No. of Shareholders 621

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

Concalls

  • Mar 2026
    Transcript
    AI Summary
    PPT